Home/Century Therapeutics/Osvaldo (Oz) Flores, Ph.D.
O(

Osvaldo (Oz) Flores, Ph.D.

President & Chief Operating Officer

Century Therapeutics

Century Therapeutics Pipeline

DrugIndicationPhase
CNTY-101Relapsed/Refractory B-cell Malignancies (e.g., NHL, CLL)Phase 1
CNTY-102Relapsed/Refractory AML & other CD123+ hematologic cancersPreclinical
CNTY-107Multiple MyelomaPreclinical
iT Cell ProgramsSolid TumorsDiscovery/Preclinical
Autoimmune ProgramsUndisclosed Autoimmune DiseasesDiscovery